A growing number of cases of a hybrid COVID-19 variant dubbed “Deltacron” are being identified, including several cases in the United States. Researchers with Helix, a California-based genomic company, found two cases of COVID-19 infection caused by a hybrid of the Delta and Omicron variants, while researchers in France determined 18 people were infected by…
Growing Number of Countries Identify Cases of ‘Deltacron’ Variant
March 12, 2022
admin
BrightCCP VirusCovid NewsCOVID-19Editor's PicksHealth NewsMind & BodyPUBLIC HEALTH INFORMATIONvariant
0 Comment
Parents Should Ask These Questions Before Giving Their Child a COVID-19 Vaccine: ER Doctor
March 11, 2022
admin
AMERICABrightCCP Viruschild vaccinationCovid NewsEditor's PicksHealth NewsMind & BodyPUBLIC HEALTH INFORMATIONUSUS NewsVaccines & Safety
0 Comment
For parents who are contemplating whether their child should receive a COVID-19 vaccine, Dr. Joseph Fraiman, an emergency medicine physician, says they should ask the following two questions to help them decide. “The first thing that you want to do for harm/benefit analysis [is to ask], is there a mortality benefit for these vaccines for…
Health Officials End Reporting COVID-19 Deaths
Commentary Data is the foundation of scientific analysis. Without data, researchers are left unable to draw conclusions, which leaves public health experts unable to accurately make recommendations. But that appears to be exactly what the CDC and Health and Human Services (HHS) are doing. The CDC is hiding data and the HHS is no longer…
Pfizer to Ask US Regulators to Authorize Second Booster Due to Waning Effectiveness: CEO
March 11, 2022
admin
Albert BourlaAMERICABrightBusiness & EconomyBusinesses in COVID-19CCP VirusCovid NewsEditor's PicksHealth NewsMind & BodyPfizerUSUS NewsVaccines & Safety
0 Comment
Pfizer plans to ask U.S. regulators to grant emergency use authorization for a second booster of its COVID-19 vaccine, CEO Albert Bourla said March 11. “Clearly there is a need in an environment of Omicron to boost the immune response,” Bourla said on CNBC’s “Squawk Box.” Pfizer’s vaccine waned over time in protection against both…
Massachusetts to Reduce ‘Significant Overcount’ of COVID-19 Deaths
March 11, 2022
admin
AMERICABrightCCP VirusCovid NewsCOVID-19 deathCOVID-19 death countEditor's PicksHealth NewsMassachusetts Public Health DepartmentMind & BodyPolicies & ImpactsPUBLIC HEALTH INFORMATIONRegional NewsRegional-Local NewsUSUS News
0 Comment
The Massachusetts Public Health Department announced Thursday that the state would lower its COVID-19 death count by 3,700 due to new measuring criteria being implemented. The department said in a statement the new death definition is following the guidance (pdf) of the Council of State and Territorial Epidemiologists and the U.S. Centers for Disease Control…
Pfizer Begins Study of COVID-19 Pill in High-Risk Children
March 10, 2022
admin
AMERICABrightBusiness & EconomyBusinesses in COVID-19CCP VirusCovid NewsCOVID-19Health NewsMind & BodyPfizerUSUS News
0 Comment
Pfizer has started a study of its COVID-19 pill in children who have COVID-19 and are designated as high-risk for experiencing severe symptoms. The phase 2/phase 3 study has approximately 140 participants between the ages of 6 and 17. One cohort will receive Pfizer’s pill, known as Paxlovid or nirmatrelvir, twice a day for five…
Even Mild Cases of COVID-19 Can Lead to Brain Changes: Study
March 8, 2022
admin
BRAINBrightCCP VirusCovid NewsCOVID-19Health NewsMind & BodyPUBLIC HEALTH INFORMATIONSymptoms & Long CovidUKWorld
0 Comment
Mild COVID-19 cases were linked to changes in the brain in a newly published study. Approximately 785 people underwent a brain scan and about half later tested positive for COVID-19. All the people got a second brain scan, including those who had survived the disease. Researchers from the Wellcome Centre for Integrative Neuroimaging at the University…
Ivermectin Linked to Less Deaths in COVID-19 Patients Compared to Remdesivir: Study
March 8, 2022
admin
BrightCCP VirusCovid NewsHealth NewsIvermectinMind & BodyPUBLIC HEALTH INFORMATIONRemdesivirScienceScience NewsUSUS NewsWorld
0 Comment
In the treatment of COVID-19, ivermectin use is associated with decreased mortality compared to remdesivir use, according to a study published in the International Journal of Infectious Diseases. Researchers at the University of Miami retrospectively analyzed a national federated database of adults 18 years old and above with a recorded COVID-19 infection between January 2020…
Ivermectin Linked to Fewer Deaths in COVID-19 Patients Compared to Remdesivir: Study
March 8, 2022
admin
BrightCCP VirusCovid NewsHealth NewsIvermectinMind & BodyPUBLIC HEALTH INFORMATIONRemdesivirScienceScience NewsUSUS NewsWorld
0 Comment
In the treatment of COVID-19, ivermectin use is associated with decreased mortality compared to remdesivir use, according to a study published in the International Journal of Infectious Diseases. Researchers at the University of Miami retrospectively analyzed a national federated database of adults 18 years old and above with a recorded COVID-19 infection between January 2020…
Long COVID: An Explainer and Research Roundup
As the COVID-19 pandemic enters its third year, researchers are learning more about the long-term effects of the infection and about a collection of symptoms and complications commonly called long COVID. Shortness of breath, fatigue and “brain fog” are among the most common symptoms of long COVID. For some, these symptoms persist after getting infected…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`